Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder
- 1 January 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 64 (1) , 104123
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mutations in the PP2A regulatory subunit B family genesPPP2R5B,PPP2R5CandPPP2R5Dcause human overgrowthHuman Molecular Genetics, 2015
- Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismFrontiers in Genetics, 2014
- The impact of chromosomal microarray on clinical management: a retrospective analysisGenetics in Medicine, 2014
- De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthoodNature Genetics, 2013
- Treatment of Neurodevelopmental Disorders in AdulthoodThe Journal of Neuroscience, 2012
- Mice lacking phosphatase PP2A subunit PR61/B’δ ( Ppp2r5d ) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3βProceedings of the National Academy of Sciences, 2011
- Adult reversal of cognitive phenotypes in neurodevelopmental disordersJournal of Neurodevelopmental Disorders, 2009
- α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cellsJournal of Cell Science, 2005
- The B56 Family of Protein Phosphatase 2A (PP2A) Regulatory Subunits Encodes Differentiation-induced Phosphoproteins That Target PP2A to Both Nucleus and CytoplasmJournal of Biological Chemistry, 1996
- Assignment of Human Protein Phosphatase 2A Regulatory Subunit Genes B56α, B56β, B56γ, B56δ, and B56ϵ (PPP2R5A–PPP2R5E), Highly Expressed in Muscle and Brain, to Chromosome Regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 → p12Genomics, 1996